Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Preventive Vaccines Market, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. This report features an extensive study…
CAMBRIDGE, Mass. & LA JOLLA, Calif.–(BUSINESS WIRE)–Cullinan Oncology LLC and PDI Therapeutics, a portfolio company of Avalon Ventures, today announced…
DUBLIN–(BUSINESS WIRE)–The “Clinical Manufacturing Market Dynamics and Service Provider Benchmarking” report has been added to ResearchAndMarkets.com’s offering. This report provides…
Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash Sofinnova Partners co-founded Corvidia as its…
New centers in St. Louis and St. Ann, Mo. open to support an urgent patient need for human plasma, including…
BEIJING & SAO PAULO–(BUSINESS WIRE)–Sinovac Biotech Ltd., (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in…
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER): The results of Omeros’ pivotal trial of narsoplimab for the treatment of hematopoietic stem cell…
SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for…
MELBOURNE, Australia–(BUSINESS WIRE)–Antisense Therapeutics (ASX:ANP | US OTC:ATHJY), an Australian biopharmaceutical company developing and commercializing antisense pharmaceuticals for unmet need…
MELBOURNE, Australia–(BUSINESS WIRE)–Antisense Therapeutics (ASX:ANP | US OTC:ATHJY), an Australian biopharmaceutical company developing and commercializing antisense pharmaceuticals for unmet need…